CHICAGO — Intravitreal triamcinolone and intravitreal dexamethasone sustained-release implant were both superior to periocular triamcinolone for the regional treatment of uveitic macular edema, ...

A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...

December 22, 2009 — Intravitreal use of the corticosteroid triamcinolone may slow the progression of diabetic retinopathy, but adverse effects including cataract formation and glaucoma may prevent use ...

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

Three modalities have a role in the primary management of diabetic macular edema (DME): laser photocoagulation, intravitreal vascular endothelial growth factor (VEGF) inhibitors, and intravitreal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Uveitic macular edema (UME) is the leading cause of ...

Dexamethasone implants appear to be the best treatment for persistent or recurrent macular edema that often occurs in patients with uveitis, findings from a new study show. The 12-week, multicenter, ...

Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a new study.

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

Treatment of ocular toxoplasmosis is highly controversial. Results of such treatment depend on host factors, such as age and immune status, as well as on parasite factors. 1 The use of corticosteroids ...

The overarching mission of the Moran Eye Center’s Uveitis Division consists of three parts: to provide state-of-the-art, comprehensive, timely, and compassionate care to patients; to serve as leaders ...